Journal of Pharmacy And Bioallied Sciences

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 7  |  Issue : 3  |  Page : 226--229

Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study


Satya Bhgath Gorityala1, Uday Venkat Mateti2, Venkateswarlu Konuru1, Srinivas Martha3 
1 Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda, Warangal, Telangana, India
2 Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda, Warangal, Telangana; Department of, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India
3 Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda; Department of, Balaji Institute of Pharmacy, Laknepally, Narsampet, Warangal, Telangana, India

Correspondence Address:
Srinivas Martha
Department of Pharmacy Practice, St. Peter«SQ»s Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda; Department of, Balaji Institute of Pharmacy, Laknepally, Narsampet, Warangal, Telangana
India

Background: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. Aim: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. Materials and Methods: A cross-sectional study was carried out for a period of 9 months among PTB patients. Patients admitted with active pulmonary Koch«SQ»s and history of anti-TB treatment (ATT) for 1-month or more from any source and who returns to treatment after not taking ATT consecutively for 2 months or more were included in the study. The data were collected from the patients or their caretakers to obtain the source of treatment given previously before default, number of treatment interruptions, phase and reasons for treatment interruption treatment. Results: A total of 107 defaulters were identified during the study period. In the present study, 62.6% of the patients interrupted treatment only once, 55.34% of the patient«SQ»s early continuation (3-4 months) treatment, and 47.66% of the patient«SQ»s only one reason for the treatment interruptions during the course of the treatment. The most common reason for the treatment interruptions were felt well with TB treatment (29.53%) followed by side effects (16.06%), lack of money (8.29%), and other reasons. Conclusion: The study revealed that most of the defaulters were in the age group between 35 and 60 years, male gender, illiterates, daily wage labor, and married. The treatment interruptions were minimized by putting the efforts to improve direct supervision; pretreatment counseling and retrieve treatment interrupters were recommended.


How to cite this article:
Gorityala SB, Mateti UV, Konuru V, Martha S. Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study.J Pharm Bioall Sci 2015;7:226-229


How to cite this URL:
Gorityala SB, Mateti UV, Konuru V, Martha S. Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study. J Pharm Bioall Sci [serial online] 2015 [cited 2019 Sep 24 ];7:226-229
Available from: http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2015;volume=7;issue=3;spage=226;epage=229;aulast=Gorityala;type=0